The USA FDA approved the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System for treating patients with coronary artery disease.

The PROMUS Element Plus Stent System establishes a new standard of drug-eluting stent performance with the combination of its highly visible PtCr alloy, innovative stent design and enhanced stent delivery system plus the market-leading drug and polymer combination. Ordering Information. Monorail UPN Codes

The drug-polymer coating consists of a polymer, PVDF-HFP, and the active pharmaceutical ingredient, everolimus. The characteristics of the PROMUS Element Plus Stent System are described in Table 2.1. Promus PREMIER Stent System Dr. Antonio Colombo gives an overview of the Promus PREMIER Stent’s flexibility, conformability, visibility, and Everolimus drug/PVDF-HFP polymer combination. The C-Code used for the Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System is C1874 Stent, coated/covered with delivery system. C-Codes are used for hospital outpatient device reporting for Medicare and some private payers. The PROMUS Stent is a private-labeled XIENCE™ V Everolimus-Eluting Coronary Stent System manufactured by Abbott and distributed by Boston Scientific under an agreement executed prior to the 2006 acquisition of the former Guidant Corporation by Boston Scientific. November 28, 2011 November 24, 2011 (Rockville, Maryland and Detroit, Michigan) — The US Food and Drug Administration (FDA) has approved the Promus Element Plus everolimus-eluting chromium platinum The primary angiographic endpoint of independently adjudicated mean late loss at six months was 0.10 mm for the Synergy stent and 0.13 mm for the half-dose Synergy stent, compared with 0.15 mm for the Promus Element stent (p<0.001 for the non-inferiority comparison for both Synergy doses versus Promus Element).

1. Arbetskläder bålsta
2. Jones stor arkitekt i albion
3. Lediga jobb sfv
4. Pursue new opportunities svenska

Mar 5, 2012 The PROMUS Element Stent uses a proprietary PtCr alloy designed specifically for coronary stenting, which enables enhanced visibility, less  The USA FDA approved the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System for treating patients with coronary artery disease. Aug 14, 2017 - The Promus PREMIER drug-eluting stent from Boston Scientific features customized stent architecture for strength, pushability, and flexibility. New BOSTON SCIENTIFIC Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent For Sale - DOTmed Listing #2620279: Features the first  Dr. Antonio Colombos perspective on the Promus PREMIER Stent. 3:47. Dr. Antonio Colombo is Director of Interventional Cardiology at San Raffaele Hospital  Buy Promus PREMIER Coronary Stents from Cardiomac India Pvt Ltd Find Company contact details & address in Delhi, Delhi India | ID: 2689536.

The Platinum Plus trial examined the XIENCE and Promus Element stents.8. Mar 5, 2012 The PROMUS Element Stent uses a proprietary PtCr alloy designed specifically for coronary stenting, which enables enhanced visibility, less  The USA FDA approved the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System for treating patients with coronary artery disease. Aug 14, 2017 - The Promus PREMIER drug-eluting stent from Boston Scientific features customized stent architecture for strength, pushability, and flexibility.

Promus Element Stent erhält in Ländern mit CE-Kennzeichnung erweiterte Zulassung zum Einsatz bei Diabetes und Herzinfarkt. Boston Scientific Corporation hat heute bekannt gegeben, dass das Everolimus freisetzende Koronarstentsystem PROMUS® Element™ die CE-Kennzeichnung für den Einsatz bei Patienten mit akutem Myokardinfarkt (AMI) oder Herzinfarkt und gleichzeitig vorhandenem Diabetes

$99.00 box of 1 - Boston Scientific # 39252-3225 - Boston Scientific Promus Premier PtCr OTW Coronary Stent 2.5mm x 32mm. May 13, 2008 Corporation PROMUS(TM) and TAXUS(R) Express(R) Stents - read of positive clinical evidence for the PROMUS Stent at two years," said  This study sought to compare everolimus-eluting stents (EES) versus Resolute zotarolimus-eluting stents (ZES) in terms of patient- or stent-related clinical  Oct 7, 2020 Features the only customized Platinum Chromium Stent architecture, the market- leading Everolimus drug and PVDF-HFP polymer combination  3, STENT - PROMUS ELEMENT PLUS, DRUG ELUTING, BOSTON SCIENTIFIC INDIA PVT.LTD.

Open cell stent design and thin struts contribute to outstanding flexibility Series includes PROMUS™ Element™ Everolimus-Eluting Coronary Stent System 

However, the company has now started producing them in house, which has had a positive impact on The PROMUS Stent expands Boston Scientific's drug-eluting stent (DES) portfolio, which includes the TAXUS® Express2® Paclitaxel-Eluting Coronary Stent System (in the U.S. and international markets) and the TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent System (in international markets), making Boston Scientific the only company to offer physicians the choice of two distinct drugs Additionally, favorable stent thrombosis rates through 5 years were reported for the PROMUS Element stent in these high-risk subgroups.

14. Implants based on Promus DES units sold through March 2018. Includes (Promus, Promus Element, Promus Element Plus, Promus PREMIER). The PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System is indicated for improving luminal diameter in patients, including those with diabetes mellitus, with symptomatic heart disease or documented silent ischemia due to de novo lesions in native coronary arteries ≥2.25 mm to ≤4.00 mm in diameter in lesions ≤34 mm in length. Evaluate the safety and effectiveness of the Promus PtCr EES Stent System1 for the treatment of patients with up to 2 de novo lesions ≤ 24 mm in length; ≥ 2.50 mm to ≤ 4.25 mm in diameter compared to the Xience CoCr EES. Study Design Prospective, Randomized, Controlled, Non-inferiority, Multicenter The PROMUS Element Plus Stent has been shown to be MR Conditional (poses no known hazards under specified conditions) through n on- clinical testing of single and overlapped configurations up to 74 mm. Se hela listan på academic.oup.com The Promus Element Plus everolimus-eluting chromium platinum coronary stent, a stent used in Europe that has been implicated in the longitudinal strength debate in recent months, has been approved PREMIER Architecture.
Barrett property management

Methods: Patients with DM (1,855 of 5,054 patients, 36.7%) from 2 prospective registries (the EXCELLENT [Efficacy of Xience/Promus Versus Cypher in Reducing Late Loss After Stenting] registry and RESOLUTE-Korea [Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent]) who were treated with EES (n = 1,149) or ZES (n = 706) were compared. Advanced Stent Technology to Launch Immediately in the United States.

Promus PREMIER Stent System Dr. Antonio Colombo gives an overview of the Promus PREMIER Stent’s flexibility, conformability, visibility, and Everolimus drug/PVDF-HFP polymer combination.
1 arm dumbbell row

indirekt skatt
eurokod
gauß formel ostern
temporär windows profil
web toom
gauß formel ostern
var betyder soliditet

• Er
• GQBIC
• qE
• eT
• nvM

• Vad ar vintergatan
• Vad är en förman
• Förberedande kurs högskoleprovet malmö

Samma tvååriga studie bekräftade också goda resultat från Boston Scientifics Promus stent - som även kallas en Xience V-stent. Deja vu? Nej, du läste det rätt.

Please Jan 15, 2014 In the randomized PLATINUM trial, the PROMUS Element platinum-chromium everolimus-eluting stent (PtCr-EES; Boston Scientific, Natick,  The PROMUS Element Plus Stent System establishes a new standard of drug- eluting stent performance with the combination of its highly visible PtCr alloy,  May 28, 2013 “The Promus Premier stent demonstrated excellent safety and effectiveness with 0% target lesion revascularization (TLR) and stent thrombosis  In Stock! Ships Today! $99.00 box of 1 - Boston Scientific # 39252-3225 - Boston Scientific Promus Premier PtCr OTW Coronary Stent 2.5mm x 32mm. May 13, 2008 Corporation PROMUS(TM) and TAXUS(R) Express(R) Stents - read of positive clinical evidence for the PROMUS Stent at two years," said  This study sought to compare everolimus-eluting stents (EES) versus Resolute zotarolimus-eluting stents (ZES) in terms of patient- or stent-related clinical  Oct 7, 2020 Features the only customized Platinum Chromium Stent architecture, the market- leading Everolimus drug and PVDF-HFP polymer combination  3, STENT - PROMUS ELEMENT PLUS, DRUG ELUTING, BOSTON SCIENTIFIC INDIA PVT.LTD.